Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Regulator response
View:
Post by hmmmmmmmm on Jan 17, 2023 2:41pm

Regulator response

I received a promt and personal response from the Senior Complaint Specialist at New SRO of Canada- who had clearly read through my letter and also CC'd the Principal Regulator at OSC.

Take a moment and send them the email from my earlier post. They are clearly at their desks- and ready to protect shareholders.

The more attention investors bring to this matter- the better chance it becomes a priority for them.
Comment by jonnieboy on Jan 17, 2023 4:08pm
As did I Timely Disclosure   New SRO administers the listing exchanges' timely disclosure requirements (namely monitoring and reviewing timely disclosure of material information by issuers listed on exchanges, under National Policy 51-201 – Disclosure Standards). That said, Issuer's disclosure and continuing listing requirements and approvals, fall under the jurisdiction ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities